Carter D - Search Results

1

Recognition of activated CSF-1 receptor in breast carcinomas by a tyrosine 723 phosphospecific antibody.

Flick MB, Sapi E, Perrotta PL, Maher MG, Halaban R, Carter D, Kacinski BM. Flick MB, et al. Among authors: carter d. Oncogene. 1997 May 29;14(21):2553-61. doi: 10.1038/sj.onc.1201092. Oncogene. 1997. PMID: 9191055

2

Expression of CSF-I and CSF-I receptor by normal lactating mammary epithelial cells.

Sapi E, Flick MB, Rodov S, Carter D, Kacinski BM. Sapi E, et al. Among authors: carter d. J Soc Gynecol Investig. 1998 Mar-Apr;5(2):94-101. doi: 10.1016/S1071-5576(97)00108-1. J Soc Gynecol Investig. 1998. PMID: 9509388

3

Prognostic significance of colony-stimulating factor receptor expression in ipsilateral breast cancer recurrence.

Maher MG, Sapi E, Turner B, Gumbs A, Perrotta PL, Carter D, Kacinski BM, Haffty BG. Maher MG, et al. Among authors: carter d. Clin Cancer Res. 1998 Aug;4(8):1851-6. Clin Cancer Res. 1998. PMID: 9717811

4

FMS (CSF-1 receptor) and CSF-1 transcripts and protein are expressed by human breast carcinomas in vivo and in vitro.

Kacinski BM, Scata KA, Carter D, Yee LD, Sapi E, King BL, Chambers SK, Jones MA, Pirro MH, Stanley ER, et al. Kacinski BM, et al. Among authors: carter d. Oncogene. 1991 Jun;6(6):941-52. Oncogene. 1991. PMID: 1829808

5

Expression of neu antigen in normal lactating and prepartum mammary epithelial cells.

Kacinski BM, Nguyen J, Carter D. Kacinski BM, et al. Among authors: carter d. J Soc Gynecol Investig. 1995 Jan-Feb;2(1):51-6. J Soc Gynecol Investig. 1995. PMID: 9420849

6

Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways.

Turner BC, Zhang J, Gumbs AA, Maher MG, Kaplan L, Carter D, Glazer PM, Hurst HC, Haffty BG, Williams T. Turner BC, et al. Among authors: carter d. Cancer Res. 1998 Dec 1;58(23):5466-72. Cancer Res. 1998. PMID: 9850080

7

Neu proto-oncogene amplification and expression in ovarian adenocarcinoma cell lines.

King BL, Carter D, Foellmer HG, Kacinski BM. King BL, et al. Among authors: carter d. Am J Pathol. 1992 Jan;140(1):23-31. Am J Pathol. 1992. PMID: 1346236 Free PMC article.

8

NEU protein overexpression in benign, borderline, and malignant ovarian neoplasms.

Kacinski BM, Mayer AG, King BL, Carter D, Chambers SK. Kacinski BM, et al. Among authors: carter d. Gynecol Oncol. 1992 Mar;44(3):245-53. doi: 10.1016/0090-8258(92)90051-j. Gynecol Oncol. 1992. PMID: 1347282

9

Ovarian adenocarcinomas express fms-complementary transcripts and fms antigen, often with coexpression of CSF-1.

Kacinski BM, Carter D, Mittal K, Yee LD, Scata KA, Donofrio L, Chambers SK, Wang KI, Yang-Feng T, Rohrschneider LR, et al. Kacinski BM, et al. Among authors: carter d. Am J Pathol. 1990 Jul;137(1):135-47. Am J Pathol. 1990. PMID: 1695482 Free PMC article.

10

The cytokine CSF-1 (M-CSF) expressed by endometrial carcinomas in vivo and in vitro, may also be a circulating tumor marker of neoplastic disease activity in endometrial carcinoma patients.

Kacinski BM, Chambers SK, Stanley ER, Carter D, Tseng P, Scata KA, Chang DH, Pirro MH, Nguyen JT, Ariza A, et al. Kacinski BM, et al. Among authors: carter d. Int J Radiat Oncol Biol Phys. 1990 Sep;19(3):619-26. doi: 10.1016/0360-3016(90)90488-6. Int J Radiat Oncol Biol Phys. 1990. PMID: 2145248

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,582 results

Search Page

Filters